l carnitine schizophrenia Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study PDF) L-Carnitine Prevents Behavioural Alterations
Description
Collectively, these untargeted metabolomic analyses indicate subtle but biologically relevant metabolic differences between ASD and control groups, characterized by increased variability and pathway-level alterations rather than complete global separation
doi: 10.1097/01.psy.0000116249.60477.e9 [DOI] [PubMed] [Google Scholar] 32
Evans A.M., Fornasini G., Pharmacokinetics of L-Carnitine, Clinical Pharmacokinetics (2003)
Karahan, M., Cokseym, B., and Arts, S
Neuroprotective effect of caffeine in Alzheimers disease
Ir J Med Sci 1994
